Approval · Notice of Compliance 17181 · 2015
PLEGRIDY: Notice of Compliance 17181
Issued August 10, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17181
- Date
- August 10, 2015
- Company
- Biogen Idec Canada Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLEGRIDY | 02444372 | Approved |
| PLEGRIDY | 02444380 | Approved |
| PLEGRIDY | 02444399 | Marketed |
| PLEGRIDY (STARTER PACK) | 02444402 | Marketed |
Medicinal ingredients
- PEGINTERFERON BETA-1A 63 MCG per 0.5ML
- PEGINTERFERON BETA-1A 94 MCG per 0.5ML
- PEGINTERFERON BETA-1A 125 MCG per 0.5ML